Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA + Idarubicin Induction and Consolidation +/- BMT or Maintenance in APL
NCT00002701Phase 3Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Oct 1995
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of tretinoin in acute promyelocytic leukemia (APL), sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.
02
Drugs
tretinoin
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00002701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002701.